Imexpharm Corporation (IMP)
Change in personnel of Imexpharm Corporation as follows:
IMP: Change in personnel
Filed with HOSE ·
6ix hasn’t read this filing yet.
Earlier from Imexpharm
- IMP: Signing an audit contract for the 2026 financial statements
- IMP: Minutes and Resolution of the General Meeting of Shareholders
- IMP: Information related to the collection of shareholders’ written opinions
- IMP: Approval of the list of candidates for members of the BOD
- IMP: Record date for collecting shareholders' written opinions
Later from Imexpharm
- IMP: Record date for 2025 cash dividend payment
- IMP: 2025 Annual Report
- IMP: 2023 Annual Report
- IMP: 2024 Annual Report
- IMP: Report on Corporate Governance for the first half of 2026
Follow Imexpharm into a list and get an email when it puts out news.
Follow Imexpharm